Because of this and TET3’s described role in DNA methylation and the aberrant expression observed in UFM carrier fibroblasts, TET3 is a candidate contributor to the pathological CGG methylation of the FMR1 promoter in FXS patient cells. This evidence concerns the gene TET3 and fragile X syndrome.